Abstract: Objectives: Iron deficiency anemia is the most common hematological but manageable health problem encountered among the pregnant women globally but more common in developing countries like India.
Methods: It is interventional prospective comparative study conducted in Department of Obstetrics and Gynaecology at Dr. Yashwant Singh Parmar Govt. Medical College & Hospital Nahan, Sirmour (H.P) over a period of 2years from April 2017- April 2019. 100 pregnant patients with hemoglobin in the range 7gm/dl - 9 gm/dl between 16 to 34 weeks gestation were selected randomly. Patients were divided into two groups 50 each. Group 1 is Iron Sucrose (IS) group- patients were treated with intravenous iron sucrose in multiple doses on alternate days on 0,2,4,6 and 8, 200mg per day, total of 1000mg. Group 2 is Ferric Carboxymaltose (FCM) group were treated with intravenous FCM 1000mg single dose. In both group Hemoglobin and Serum ferritin were assessed before and after (3 & 6 weeks) parenteral therapy.
Results: There is significant rise of hemoglobin >2 gm/dl in Group 2 (FCM) as compared to in Group 1 (Iron sucrose). The single dose regime of FCM group was having very good compliance as compared to Iron sucrose group.
Conclusion: Intravenous Ferric carboxymaltose is more effective and safer as compared to Intravenous Iron sucrose in the management of anemia during pregnancy.
Indexed in Index Copernicus
